S&P 500

6.025,99

-0,95%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Fluidigm Corporation (FLDM)
Fluidigm Corporation (FLDM) Notícias

FLDM

Fluidigm (FLDM)

Fluidigm Corporation

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:FLDM

1 2 3 4 5 6 7 8 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
20/06/2023	07:01	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:FLDM	Fluidigm Corporation
22/05/2023	19:50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FLDM	Fluidigm Corporation
15/05/2023	18:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:FLDM	Fluidigm Corporation
09/05/2023	18:14	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:FLDM	Fluidigm Corporation
28/04/2023	17:46	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:FLDM	Fluidigm Corporation
28/04/2023	17:38	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:FLDM	Fluidigm Corporation
17/03/2023	18:11	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:FLDM	Fluidigm Corporation
14/02/2023	18:53	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:FLDM	Fluidigm Corporation
09/02/2023	18:03	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:FLDM	Fluidigm Corporation
30/12/2022	19:11	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:FLDM	Fluidigm Corporation
31/05/2022	08:31	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	NASDAQ:FLDM	Fluidigm Corporation
27/05/2022	14:34	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:FLDM	Fluidigm Corporation
17/05/2022	17:04	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:FLDM	Fluidigm Corporation
08/04/2022	18:08	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:FLDM	Fluidigm Corporation
04/04/2022	18:30	GlobeNewswire Inc.	Fluidigm Completes $250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc.	NASDAQ:FLDM	Fluidigm Corporation
01/04/2022	17:05	GlobeNewswire Inc.	Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion	NASDAQ:FLDM	Fluidigm Corporation
29/03/2022	10:39	Edgar (US Regulatory)	Revised Proxy Soliciting Materials (definitive) (defr14a)	NASDAQ:FLDM	Fluidigm Corporation
29/03/2022	10:29	GlobeNewswire Inc.	Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital Infusion by Casdin Capital and Viking Global	NASDAQ:FLDM	Fluidigm Corporation
28/03/2022	09:30	GlobeNewswire Inc.	Fluidigm Highlights the Strategic Capital Infusion by Casdin Capital and Viking Global as the Only Actionable Financing Solution	NASDAQ:FLDM	Fluidigm Corporation
25/03/2022	17:00	GlobeNewswire Inc.	Fluidigm Adjourns Special Meeting of Stockholders Until April 1, 2022	NASDAQ:FLDM	Fluidigm Corporation
21/03/2022	09:00	GlobeNewswire Inc.	Fluidigm Urges Stockholders to Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion TODAY	NASDAQ:FLDM	Fluidigm Corporation
17/03/2022	18:58	GlobeNewswire Inc.	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion	NASDAQ:FLDM	Fluidigm Corporation
17/02/2022	19:43	GlobeNewswire Inc.	Fluidigm Announces Fourth Quarter and Full Year 2021 Financial Results	NASDAQ:FLDM	Fluidigm Corporation
17/02/2022	10:30	GlobeNewswire Inc.	Fluidigm Announces Collaboration Agreement with the Abu Dhabi Stem Cells Center to Accelerate Imaging Mass Cytometry in Development of Targeted Stem Cell Therapies	NASDAQ:FLDM	Fluidigm Corporation
14/02/2022	08:16	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:FLDM	Fluidigm Corporation
14/02/2022	08:10	GlobeNewswire Inc.	Fluidigm Files Preliminary Proxy Statement in Connection with Proposed Strategic Capital Infusion from Casdin Capital and Viking Global Investors	NASDAQ:FLDM	Fluidigm Corporation
11/02/2022	18:10	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:FLDM	Fluidigm Corporation
24/01/2022	10:30	GlobeNewswire Inc.	Fluidigm Announces $250 Million Strategic Capital Infusion from Casdin Capital and Viking Global Investors and Rebranding to Standard BioTools Inc.	NASDAQ:FLDM	Fluidigm Corporation
11/01/2022	10:00	GlobeNewswire Inc.	Fluidigm Announces Preliminary Revenue Exceeding Guidance for the Fourth Quarter and Full Year 2021	NASDAQ:FLDM	Fluidigm Corporation
07/12/2021	10:30	GlobeNewswire Inc.	Fluidigm Confirms Advanta Dx SARS-CoV-2 RT-PCR Assay on the Company’s Biomark Platform Detects Omicron Variant of COVID-19	NASDAQ:FLDM	Fluidigm Corporation